Gene · 8554
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction. | Elife | 2023 | 37092726 | PubTator, text mining | PubMed |
| SUMO and PIAS repress NF-κB activation in a basal chordate. | Fish Shellfish Immunol | 2023 | 37088348 | PubTator, text mining | PubMed |
| African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. | Cancer Res Commun | 2023 | 37082578 | PubTator, text mining | PubMed |
| Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification. | J Proteome Res | 2023 | 37071664 | PubTator, text mining | PubMed |
| Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis. | Transl Oncol | 2023 | 37062237 | PubTator, text mining | PubMed |
| Contribution of Epstein-Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses. | Cancers (Basel) | 2023 | 37046781 | PubTator, text mining | PubMed |
| Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review. | Front Pharmacol | 2023 | 37021053 | PubTator, text mining | PubMed |
| Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanopore. | Nat Commun | 2023 | 37015934 | PubTator, text mining | PubMed |
| Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors. | Life (Basel) | 2023 | 36983760 | PubTator, text mining | PubMed |
| Head Size in Phelan-McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13. | Genes (Basel) | 2023 | 36980813 | PubTator, text mining | PubMed |
| Identification of candidate genomic regions for egg yolk moisture content based on a genome-wide association study. | BMC Genomics | 2023 | 36918797 | PubTator, text mining | PubMed |
| Regulation of SUMOylation on RNA metabolism in cancers. | Front Mol Biosci | 2023 | 36911524 | PubTator, text mining | PubMed |
| When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases. | Int J Mol Sci | 2023 | 36902175 | PubTator, text mining | PubMed |
| Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies. | Cells | 2023 | 36899868 | PubTator, text mining | PubMed |
| RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. | Cells | 2023 | 36899853 | PubTator, text mining | PubMed |
| Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development. | Cell Death Dis | 2023 | 36899018 | PubTator, text mining | PubMed |
| Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα. | Cell Death Differ | 2023 | 36894687 | PubTator, text mining | PubMed |
| Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer. | J Ovarian Res | 2023 | 36859398 | PubTator, text mining | PubMed |
| MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy. | J Appl Genet | 2023 | 36821071 | PubTator, text mining | PubMed |
| Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. | Theranostics | 2023 | 36793866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/papers?page=9